Kyle Bass has lost another one of his inter partes review petitions. (If you need reminding who Kyle Bass is, see here and here.) I’m on a panel this coming Tuesday (9/8/2015) with a couple of people from the pharmaceutical industry. It’ll be interesting to see if they back off their attacks on inter partes review.
Tag Archive for Kyle Bass
I Called It: Kyle Bass’s First Two IPR Petitions Fail
by Matt Levy •
Kyle Bass, the hedge fund manager who filed a number of inter partes review petitions against pharmaceutical companies, has struck terror into the shriveled hearts of the pharmaceutical industry. The first petitions he filed were against Acorda Therapeutics, and its stock dropped on the news. The pharmaceutical industry immediately started lobbying to change IPR procedures…